1974
DOI: 10.1056/nejm197406272902605
|View full text |Cite
|
Sign up to set email alerts
|

BCG and Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
62
1
1

Year Published

1976
1976
2012
2012

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 184 publications
(64 citation statements)
references
References 64 publications
0
62
1
1
Order By: Relevance
“…Mycobacteria have long been known to exert a number of immunomodulatory effects and have been used extensively as a source of adjuvant preparations. The best known adjuvant is Freund's complete adjuvant consisting of a paraffin oil emulsion and heat-killed mycobacteria (15); however, live M. bovis BCG has also been used as an immunotherapeutic agent (7). Similarly, purified components of mycobacteria have been shown to have immunostimulatory activity.…”
Section: Discussionmentioning
confidence: 99%
“…Mycobacteria have long been known to exert a number of immunomodulatory effects and have been used extensively as a source of adjuvant preparations. The best known adjuvant is Freund's complete adjuvant consisting of a paraffin oil emulsion and heat-killed mycobacteria (15); however, live M. bovis BCG has also been used as an immunotherapeutic agent (7). Similarly, purified components of mycobacteria have been shown to have immunostimulatory activity.…”
Section: Discussionmentioning
confidence: 99%
“…Although the concept of immune surveillance, as a mechanism ofhost resistance to cancer, offers hope that highly specific, more effective, and less toxic therapies for tumors can be developed, extensive clinical immunotherapy trials (29,30) have not yet fulfilled expectations. In fact, the role of the immune system in cancer control has been seriously questioned.…”
Section: Discussionmentioning
confidence: 99%
“…Cell Lines and Cell Culture-CDDP-sensitive OV2008 (17) and A2780s (18,19) and CDDP-resistant C13* (20), OVCA420 (21), OVCA433 (22,23), and HEY (24) human ovarian cancer cell lines were derived from serous cystadenocarcinomas of the ovary. The C13* cell line is the isogenic resistant counterpart to OV2008, selected by chronic exposure of increasing concentrations of CDDP.…”
Section: Methodsmentioning
confidence: 99%